Pappas Capital is a global venture capital and commercial development firm specializing in investments in next-generation life science products and technologies. Founded in 1994, the firm has invested in over 100 companies across the United States, Canada, and Asia, focusing on innovative solutions in life sciences. They have successfully brought products to market that have treated various conditions, contributing to billions of dollars in revenue.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions